CRIP1重塑胃癌微环境,以促进淋巴转移的发展
Zhonghua Wu1, Bicheng Qu1, Minxian Yuan1
1Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors China Medical University, Ministry of Education, 155 North Nanjing Street, Heping District, Shenyang, 110001, China.
富含氨酸的肠道蛋白-1 (CRIP1) 通过增强淋巴血管生成和淋巴透性来促进胃癌的淋巴转移. 这种蛋白质影响关键信号通路,为胃癌治疗提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 淋巴转移 (LM) 是癌症进展的关键途径.
- 在胃癌 (GC) 中,淋巴血管生成和淋巴透性的机制尚未完全理解.
研究的目的:
- 研究胰岛素丰富的肠蛋白-1 (CRIP1) 在胃癌淋巴转移中的作用和机制.
- 在GC中确定CRIP1的下游目标和监管途径.
主要方法:
- 过度表达试验用于评估CRIP1对LM的影响.
- 确定CRIP1下游目标.
- 救援实验以验证监管轴效应的有效性.
主要成果:
- 过度表达CRIP1促进淋巴血管生成和淋巴血管透性在GC.
- 通过CREB1酸化,CRIP1可以调节血管内皮生长因子C (VEGFC).
- 克里普1增强C-C动机化学因配体5 (CCL5) 的表达,招募巨细胞,促进TNF-α的分泌,增加淋巴通透性.
结论:
- 克里普1在促进GC淋巴血管生成和LM方面发挥着重要作用.
- CRIP1-CREB1-VEGFC和CRIP1-CCL5-巨细胞-TNF-α通路是关键的调节者.
- CRIP1及其相关途径代表了GC的潜在治疗点.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
相关概念视频
Cancer Cell Migration through Invadopodia
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
